Next Article in Journal
Synthesis and Biodegradation of Poly(l-lactide-co-β-propiolactone)
Next Article in Special Issue
Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin
Previous Article in Journal
Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”
Previous Article in Special Issue
Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration

Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity

Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University, Nanjing 210096, China
School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China
State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, China
Shandong Provincial Key Laboratory of Animal Resistance Biology, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Jinan 250014, China
Authors to whom correspondence should be addressed.
Academic Editors: John H. Miller and Susan L. Mooberry
Int. J. Mol. Sci. 2017, 18(6), 1267;
Received: 30 March 2017 / Revised: 9 June 2017 / Accepted: 11 June 2017 / Published: 20 June 2017
(This article belongs to the Special Issue Microtubule-Targeting Agents)
Centrosome aberrations have been implicated in the development and progression of breast cancer. Our previous worked show that centrosomal protein 70 (Cep70) regulates breast cancer growth and metastasis. However, it remains elusive whether Cep70 is implicated in the sensitivity of the anti-microtubule drug paclitaxel in breast cancer. Here we provide evidence that Cep70 is a mediator of paclitaxel sensitivity in breast cancer. Cell proliferation assays show that Cep70 expression correlates with paclitaxel sensitivity in breast cancer cell lines. In addition, paclitaxel sensitivity varies when altering Cep70 expression level. Mechanistic studies reveal that Cep70 interacts with tubulin, and promotes the ability of paclitaxel to stimulate microtubule assembly. These data demonstrate that Cep70 mediates paclitaxel sensitivity in breast cancer. View Full-Text
Keywords: Cep70; microtubule; paclitaxel sensitivity; breast cancer Cep70; microtubule; paclitaxel sensitivity; breast cancer
Show Figures

Figure 1

MDPI and ACS Style

Shi, X.; Wang, Y.; Sun, X.; Wang, C.; Jiang, P.; Zhang, Y.; Huang, Q.; Liu, X.; Li, D.; Zhou, J.; Liu, M. Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity. Int. J. Mol. Sci. 2017, 18, 1267.

AMA Style

Shi X, Wang Y, Sun X, Wang C, Jiang P, Zhang Y, Huang Q, Liu X, Li D, Zhou J, Liu M. Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity. International Journal of Molecular Sciences. 2017; 18(6):1267.

Chicago/Turabian Style

Shi, Xingjuan; Wang, Yujue; Sun, Xiaoou; Wang, Chan; Jiang, Peng; Zhang, Yu; Huang, Qinghai; Liu, Xiangdong; Li, Dengwen; Zhou, Jun; Liu, Min. 2017. "Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity" Int. J. Mol. Sci. 18, no. 6: 1267.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop